Kashyap Shreya Singh, Kaur Surmeet, Devgan Rajiv Kumar, Singh Sumitoj, Singh Jatinder, Kaur Manpreet
Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
Department of Radiotherapy and Oncology, Government Medical College, G.N.D. Hospital, Amritsar, Punjab, India.
Biochem Genet. 2024 Jul 26. doi: 10.1007/s10528-024-10894-3.
The immune system plays a bifaceted role in tumour development through modulation of inflammation. MBL binds to damage-associated molecular patterns and induces inflammation through the activation of complement pathway. Dysregulated inflammation plays a major role in breast cancer pathogenesis, thereby suggesting its contribution towards breast cancer risk. Literature asserts single-nucleotide polymorphisms (SNPs) modulating serum MBL levels. Therefore, studying MBL2 SNPs in breast cancer might provide valuable insight in the disease pathogenesis. The present case-control association study aimed to elucidate the association between MBL2 5' near gene SNPs and breast cancer risk. Breast cancer patients were recruited from Government Medical College, G.N.D. Hospital, Amritsar. The age- and gender-matched genetically unrelated healthy individuals, from adjoining regions, with no history of malignancy up to three generations were recruited as controls. The SNPs of MBL2 from the 5' near gene region with putative functional significance were selected based upon the in silico analysis and literature review. The genotypic, allelic and haplotype frequencies for the studied variants were assessed and compared in the study participants by ARMS-PCR and PCR-RFLP. No difference in allelic, genotypic and haplotype frequencies was reported for rs7096206, rs7084554 and rs11003125 in both the participant groups. rs7084554 (CC) was found to confer risk towards hormone receptor-positive breast cancer. An intermediate LD was observed between rs7084554 and rs11003125. The study reports association between MBL2 variant (rs7084554) and hormone receptor-positive breast cancer risk. Further research in this direction might validate the findings.
免疫系统通过调节炎症在肿瘤发展中发挥双重作用。甘露聚糖结合凝集素(MBL)与损伤相关分子模式结合,并通过激活补体途径诱导炎症。炎症失调在乳腺癌发病机制中起主要作用,从而提示其与乳腺癌风险有关。文献表明单核苷酸多态性(SNP)可调节血清MBL水平。因此,研究乳腺癌中的MBL2 SNP可能为该疾病的发病机制提供有价值的见解。本病例对照关联研究旨在阐明MBL2 5'侧翼基因SNP与乳腺癌风险之间的关联。乳腺癌患者从阿姆利则的政府医学院G.N.D.医院招募。从相邻地区招募年龄和性别匹配的无血缘关系的健康个体作为对照,这些个体三代以内无恶性肿瘤病史。基于计算机分析和文献综述,从5'侧翼基因区域选择具有假定功能意义的MBL2 SNP。通过扩增阻滞突变系统聚合酶链反应(ARMS-PCR)和聚合酶链反应-限制性片段长度多态性(PCR-RFLP)评估并比较研究参与者中所研究变异的基因型、等位基因和单倍型频率。两组参与者中rs7096206、rs7084554和rs11003125的等位基因、基因型和单倍型频率均无差异。发现rs7084554(CC)与激素受体阳性乳腺癌风险相关。在rs7084554和rs11003125之间观察到中等程度的连锁不平衡。该研究报告了MBL2变异(rs7084554)与激素受体阳性乳腺癌风险之间的关联。在这个方向上的进一步研究可能会验证这些发现。